Assessment of a cancer screening program

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 6, 2015, Pages 979-985

  Rabeneck, Linda ^a,b   Lansdorp Vogelaar, Iris ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cancer screening; Cancer screening evaluation; Colorectal cancer screening; Modeling

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MODEL; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; EUROPEAN UNION; HUMAN; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING TEST; ASIA; COLORECTAL NEOPLASMS; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; MASS SCREENING;

ASIA; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING;

EID: 84962262901     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.09.009     Document Type: Review

References (17)

1. B. Towler, L. Irwig, P. Glasziou, J. Kewenter, D. Weller, and C. Silagy A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult BMJ 317 7158 1998 559 565
2. B.J. Elmunzer, R.A. Hayward, P.S. Schoenfeld, S.D. Saini, A. Deshpande, and A.K. Waljee Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials PLoS Med 9 12 2012 e1001352
3. J.J. Sung, S.C. Ng, F.K. Chan, H.M. Chiu, H.S. Kim, T. Matsuda, and et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening Gut 64 2015 121 132
4. L. Rabeneck, S. Horton, A.G. Zauber, and C. Earle Colorectal Cancer Dean T. Jamison, Hellen Gelbrand, Sue Horton, Prabhat Jha, Ramanan Laximinarayan, Rachel Nugent, Disease control priorities in developing countries 3rd ed. vol. 6 2015 World Bank Washington, DC chapter 6. [Forthcoming]
5. IARC (International Agency for Research on Cancer) Handbook of cancer prevention Cervix cancer screening vol. 10 2010 IARC Press Lyon, France
6. A. Miles, J. Cockburn, R.A. Smith, and J. Wardle A perspective from countries using organized screening programs Cancer 101 2004 1201 1213
7. L. von Karsa, T.A. Lignini, J. Patnick, R. Lambert, and C. Sauvaget The dimensions of the CRC problem Best Pract Res Clin Gastroenterol 24 2010 381 396
8. S.J. Lee, W.J. Boscardin, I. Stijacic-Cenzer, J. Conell-Price, S. O'Brien, and L.C. Walter Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark Br Med J 346 2013 E8441
9. S. Moss, R. Ancelle-Park, and H. Brenner Evaluation and interpretation of screening outcomes N. Segnan, J. Patnick, L. von Karsa, European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010 Publications Office of the European Union Luxembourg
10. F. Van Hees, A.G. Zauber, H. van Veldhuizen, M.L. Heijnen, C. Penning, H.J. de Koning, and et al. The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands Gut June 10, 2015 [in press]
11. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, T.R. Levin, P. Lavin, G.P. Lidgard, and et al. Multitarget stool DNA testing for colorectal-cancer screening N Engl J Med 370 14 2014 1287 1297
12. S.D. Saini, F. van Hees, and S. Vijan Smarter screening for cancer: possibilities and challenges of personalization JAMA 312 21 2014 2211 2212
13. I. Lansdorp-Vogelaar, A.B. Knudsen, and H. Brenner Cost-effectiveness of colorectal cancer screening Epidemiol Rev 33 2011 88 100
14. M.E. van den Akker-van Marle, M. van Ballegooijen, G.J. van Oortmarssen, R. Boer, and J.D. Habbema Cost-effectiveness of cervical cancer screening: comparison of screening policies J Natl Cancer Inst 94 3 2002 193 204
15. M. Rebolj, M. van Ballegooijen, F. van Kemenade, C. Looman, R. Boer, and J.D. Habbema No increased risk for cervical cancer after a broader definition of a negative pap smear Int J Cancer 123 11 2008 2632 2635
16. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, J. Wilschut, M. van Ballegooijen, and K.M. Kuntz Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 9 2008 659 669
17. D.R. Cenin, D.J. St John, M.J. Ledger, T. Slevin, and I. Lansdorp-Vogelaar Optimising the expansion of the national bowel cancer screening program Med J Aust 201 8 2014 435 436